Table of Contents

• RISK ASSESSMENT ADVISOR COMES TO CVM [ARCHIVED]
• FDA SPONSORS NARMS SCIENTIFIC MEETING [ARCHIVED]
  by Marcia L. Headrick, D.V.M., M.P.H.
• ANTIMICROBIAL RESISTANCE IN SALMONELLA ISOLATES FROM EXOTIC ANIMALS, NARMS 1997-1999 [ARCHIVED]
  by M.L. Headrick (FDA-CVM, Athens, GA), L.A. Walker (FDA-CVM, Rockville, MD), and P.J. Fedorka-Cray (USDA-ARS-ARRU, Athens, GA)
• COMPLIANCE POLICY GUIDE IN EFFECT FOR THE EXTRA-LABEL USE OF MEDICATED FEEDS IN MINOR SPECIES [ARCHIVED]
  by Meg Oeller, D.V.M.
• FDA APPROVES FIRST INJECTABLE HEARTWORM DRUG FOR DOGS [ARCHIVED]
• COMPANION ANIMAL ANESTHETIC APPROVALS [ARCHIVED]
  by Germaine Connolly, D.V.M.
• PET FOOD: THE LOWDOWN ON LABELS [ARCHIVED]
  by Linda Bren
• APPROVAL WITHDRAWN FOR ABBOTT LABORATORIES' POULTRY FLUOROQUINOLONE DRUGS [ARCHIVED]
• PATHOGEN LOAD REPORT AVAILABLE [ARCHIVED]
• REGULATORY ACTIVITIES - July/August 2001 [ARCHIVED]
• NEW ANIMAL DRUG APPROVALS - July/August 2001 [ARCHIVED]
• SUPPLEMENTAL NEW ANIMAL DRUG APPROVALS - July/August 2001 [ARCHIVED]